OOIR: Observatory of International Research

Papers

(The TQCC of Best Practice & Research Clinical Endocrinology & Metabolism is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	91
Editorial Board	90
Editorial Board	89
The pathophysiology of hypophosphatemia	86
Publisher's Note	61
Editorial Board	59
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency	50
Burosumab: Current status and future prospects	45
Premature ovarian insufficiency, early menopause, and induced menopause	44
SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG	42
Editorial Board	42
Genetics of reproductive endocrinology	41
Genotype-phenotype correlations in Graves’ disease	40
Developments in interventional management of hepatic metastases from neuroendocrine tumours	40
Editorial Board	37
COVID-19 vaccination and thyroiditis	37
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	35
Editorial Board	35
Editorial Board	33
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	33
Editorial Board	33
Second line treatment of acromegaly: Pasireotide or Pegvisomant?	31
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	30
Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms	30
Editorial Board	29

Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases	27
Menopausal hormone therapy for the management of osteoporosis	27
Clinical imaging of marrow adiposity	26
Myeloma and marrow adiposity: Unanswered questions and future directions	26
Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma	26
Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?	26
Nonalcoholic fatty liver disease and adult growth hormone deficiency: An under-recognized association?	24
Newly detected diabetes during the COVID-19 pandemic: What have we learnt?	24
Post cancer care in women with an increased risk of malignancy or previous malignancy: The use of hormone replacement therapy and alternative treatments	24
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	23
Endocrine disrupting chemicals and bone	22
Ageing male (part I): Pathophysiology and diagnosis of functional hypogonadism	22
Genetics of anti-Müllerian hormone and its signaling pathway	21
Common symptoms associated with usage and cessation of anabolic androgenic steroids in men	21
Genetics of congenital central hypogonadism	20
Progress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma	20
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors	20
Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children	19
Differentiated thyroid carcinoma: An update	19
Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use	19
Genetics of pubertal timing	18
Genetics of cryptorchidism and testicular regression	18
Editorial Board	17
Ageing male (part 2): Management of functional hypogonadism in older men, a patient-centric holistic approach	17
Preface	17
Pregnancy with primary hyperparathyroidism	17
Editorial Board	17
Pituitary and SARS CoV-2: An unremitting conundrum	17
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	17
Editorial Board	16
Editorial Board	16
Best practice & research clinical endocrinology & metabolism focusing on the menopause – Diagnostic and therapeutic strategies	16
Androgens part 2: Emerging areas	16
Gut microbiota and their metabolites in cardiovascular disease	15
Impact of long-acting growth hormone replacement therapy in adult growth hormone deficiency: Comparison between adolescent, adult, and elderly patients	15
Associations of prenatal exposure to phthalates and one phthalate substitute with anthropometric measures in early life: Results from the German LIFE Child cohort study	15
Coronavirus disease 2019 and vitamin D	15
Effects of endocrine disorders on lipids and lipoproteins	15
Thyroid autoimmunity and pregnancy in euthyroid women	15
Chemokines in thyroid autoimmunity	15
Regulation of bone mass: A splendid Orchestra	15
Editorial Board	15
Epigenetic regulation of bone mass	15
COVID-induced thyroid autoimmunity	15
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?	15